Select A Menu Option
Meet Our Team
Physician Advantages
Sponsor Advantages
Our Values
Current Studies
Who Can Be In A
Clinical Trial?
Contact Us
Our Home Page

Send Us An Email
 
 
Ragweed Allergy
Are you suffering from rhinoconjunctivitis caused by ragweed?
 
Heartland Medical Research is participating in a medical research study patients with rhinoconjunctivitis. The investigational medication is a specific allergen vaccine containing the ragweed allergen extract in a tablet form that dissolves quickly under the tongue. As a tablet, it may become a useful and safe treatment that is easy to take and may help reduce the symptoms of rhinoconjunctivitis and reduce the chance of severe side effects.
 
Rhinoconjunctivitis is the medical term for inflammation (swelling) inside of the nose and the outermost layer of the eye. Symptoms associated with rhinoconjunctivitis may include nasal irritation, runny nose or post nasal drip, nasal congestion, redness, swelling, itching and irritation of your eyes. Ragweed allergy symptoms occur in late summer/early fall.
 
You may be eligible to participate in this study if your meet the following criteria:
 
• 18 to 50 years of age with a history of significant ragweed-induced allergic rhinoconjunctivitis of 2 years or more and have received treatment during the previous ragweed season.
• Have not received previous treatment by immunotherapy with ragweed allergen or any other allergen within the past 5 years.
• Do not have mild to moderate asthma requiring medium or high-dose inhaled corticosteroids.
 
Eligible participants will receive study-related medical evaluations and investigational study medication at no cost; medical insurance in not required. Reimbursement for time and travel may also be provided.
 
If this sounds like something you might qualify for, please contact our office or fill out our online information form.
   
   
    © Heartland Medical Research, Inc. | 2024 NW 92nd Court, Suite 8 | Clive, Iowa 50325
PH: 515-225-6050 | FX: 515-225-1035